APPLICATION OF PRIMARY HUMAN HEPATOCYTES ENRICHED WITH HUMAN PLASMA IN CYP INDUCTION STUDIES

被引：0
|
作者：
Lu, Chuang [1 ]
Amaral, Kirsten [2 ]
Ho, David [2 ]
Li, Albert P. [2 ]
机构：
[1] Sanofi, Waltham, MA USA
[2] IVAL, Columbia, MD USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2020年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P90
引用
收藏
页码：S49 / S50
页数：2
相关论文
共 50 条
  • [21] USE OF PRIMARY CULTURES OF HUMAN HEPATOCYTES IN TOXICOLOGY STUDIES
    BUTTERWORTH, BE
    SMITHOLIVER, T
    EARLE, L
    LOURY, DJ
    WHITE, RD
    DOOLITTLE, DJ
    WORKING, PK
    CATTLEY, RC
    JIRTLE, R
    MICHALOPOULOS, G
    STROM, S
    CANCER RESEARCH, 1989, 49 (05) : 1075 - 1084
  • [22] PREDICTION OF CYP2B6 AND 3A4 INDUCTION POTENTIAL WITH RIS IN PRIMARY HUMAN HEPATOCYTES
    Sun, Jun
    Carvalho, Bruno
    Shebley, Mohamad
    Lau, Yau
    de Morais, Sonie
    Rajaraman, Ganesh
    DRUG METABOLISM REVIEWS, 2015, 47 : 125 - 125
  • [23] Lack of induction of CYP2C9 by seven herbal components in primary cultured human hepatocytes.
    He, N.
    Cai, H.
    Hamm, C.
    Edeki, T.
    Strom, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S43 - S43
  • [24] EXPANDED PRIMARY HUMAN HEPATOCYTES ENABLE METABOLISM STUDIES INCLUDING CYP2D6 DEPENDENT PATHWAYS (UPCYTE® HEPATOCYTES)
    Noerenberg, Astrid
    Runge, Nils
    Schroth, Werner
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S63 - S63
  • [25] Arsenite decreases CYP3A4 and RXRα in primary human hepatocytes
    Noreault, TL
    Kostrubsky, VE
    Wood, SG
    Nichols, RC
    Strom, SC
    Trask, HW
    Wrighton, SA
    Evans, RM
    Jacobs, JM
    Sinclair, PR
    Sinclair, JF
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 993 - 1003
  • [26] Lapatinib Metabolism in CYP3A5-Genotyped Primary Human Hepatocytes
    Bissada, Jennifer
    Abouda, Arsany
    Jackson, Klarissa
    FASEB JOURNAL, 2019, 33
  • [27] Metabolism and CYP-inducer properties of astaxanthin in man and primary human hepatocytes
    A. Kistler
    H. Liechti
    L. Pichard
    E. Wolz
    G. Oesterhelt
    A. Hayes
    P. Maurel
    Archives of Toxicology, 2002, 75 : 665 - 675
  • [28] Metabolism and CYP-inducer properties of astaxanthin in man and primary human hepatocytes
    Kistler, A
    Liechti, H
    Pichard, L
    Wolz, E
    Oesterhelt, G
    Hayes, A
    Maurel, P
    ARCHIVES OF TOXICOLOGY, 2002, 75 (11-12) : 665 - 675
  • [29] Cyp induction screening in human hepatocytes with high predictive value: Application to drug candidate selection and quantitative risk assessment
    Kern, A
    DRUG METABOLISM REVIEWS, 2005, 37 : 52 - 52
  • [30] Fast LC-MS/MS method for determination of CYP1A, CYP2B and CYP3A induction in primary human hepatocytes
    Palacios, Mary A.
    Frank, Karl B.
    Moore, David J.
    DRUG METABOLISM REVIEWS, 2009, 41 : 86 - 87
12345